CEO, Junshi Biosciences
Ning Li is currently Chairman of Topalliance Biosciences. Before that he served as the Chief Executive Officer of Junshi Biosciences for 6 years. Prior to joining Junshi Biosciences, Ning had been appointed as Vice President and Head of Region Asia and China Regulatory Affairs and Medical Policy in Sanofi. He worked at US Food and Drug Administration for more than 12 years as a regulatory reviewer and held positions with increasing responsibilities. Prior to his US FDA career, he worked at the University of Iowa, Dept of Internal Medicine and Westat /NIH DATRI Clinical trial coordinator center. He is an adjunct faculty member at Johns Hopkins University and Peking University. Dr. Li obtained his medical degree from Shanghai First Medical College (Fudan University) and a doctorate degree from University of Iowa. He has published more than 30 scientific papers in the area of clinical trial methodology.